Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-70 year~* american society of anesthesiologist status 1-2~* elective general anesthesia~Exclusion Criteria:~* known or predicted difficult airway~* recent sore throat~* mouth opening less than 2.5 cm~* at risk of aspiration

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- group N (Type: ACTIVE_COMPARATOR): Anesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation.
- group R (Type: ACTIVE_COMPARATOR): Anesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.

Based on this trial design, predict the completion outcome and termination type (if applicable).